Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes are associated with an 11% lower risk of ...

The FDA has expanded the label for oral semaglutide (Rybelsus; Novo Nordisk) tablets 7 mg and 14 mg to reduce the risk of major adverse cardiovascular events (MACE) in adults with type 2 diabetes who ...

The difference between type 1 and type 2 diabetes is that people with type 2 have a wider variety of treatment options.

New research from investigators at Mass General Brigham suggests that a commonly used type 2 diabetes medication is linked to a higher rate of heart-related conditions compared to medications that hit ...

A year after Novo Nordisk surrendered its pursuit of an approval in the U.S. for IcoSema as a treatment for Type 2 diabetes, the Danish company has scored a recommendation for the combination drug in ...

SEATTLE — Use of GLP-1 receptor agonists (GLP-1s) was associated with a reduction in fragility fractures among older women with type 2 diabetes (T2D) in a retrospective analysis of data from a global ...

Use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors for the treatment of type 2 diabetes does not appear to increase the risk for urinary tract infections (UTIs) compared with two other new ...

New ICD-10 diagnosis code is for patients with history of type 2 diabetes who bring blood sugar levels to a non-diabetic ...

Drugs widely used to treat type 2 diabetes may be more likely to keep working if they are used in moderation, researchers at Washington University School of Medicine in St. Louis have found in a study ...